Medeon Biodesign Inc (6499):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Medeon Biodesign Inc (6499) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C6507
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:台湾
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Medeon Biodesign Inc (Medeon Biodesign) is a medical device company that develops patient-centered medical device products that address unmet medical needs. The company’s products include cardiovascular devices and equipment, devices for minimally invasive surgeries, laparoscopic device, high value and high impact medical device products, among others. It also provides interventional cardiovascular procedure devices, minimally invasive laparoscopic surgery devices, surgical devices and equipment, among others. Medeon Biodesign offers its products in the areas of cardiovascular, peripheral vascular, orthopedic, neurosurgery, obesity, gastroenterology, hematology, nephrology, gynecology, urology and plastic surgery, among others. The company has its operations in Taiwan and the US. Medeon Biodesign is headquartered in Taipei, Taiwan.

Medeon Biodesign Inc (6499) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Medeon Biodesign Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Medeon Biodesign Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Medeon Biodesign Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Medeon Biodesign Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Medeon Biodesign Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Medeon Biodesign Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Medeon Biodesign Raises USD28.8 Million in Offering of Ordinary Shares 10
Medeon Biodesign to Raise USD18 Million in Public offering of Shares 11
Asset Transactions 12
Terumo to Acquire Large Bore Vascular Closure System from Medeon Biodesign 12
Medeon Biodesign Inc – Key Competitors 13
Medeon Biodesign Inc – Key Employees 14
Medeon Biodesign Inc – Locations And Subsidiaries 15
Head Office 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Medeon Biodesign Inc, Medical Equipment, Key Facts, 2017 2
Medeon Biodesign Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Medeon Biodesign Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Medeon Biodesign Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Medeon Biodesign Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Medeon Biodesign Inc, Deals By Market, 2012 to YTD 2018 8
Medeon Biodesign Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Medeon Biodesign Raises USD28.8 Million in Offering of Ordinary Shares 10
Medeon Biodesign to Raise USD18 Million in Public offering of Shares 11
Terumo to Acquire Large Bore Vascular Closure System from Medeon Biodesign 12
Medeon Biodesign Inc, Key Competitors 13
Medeon Biodesign Inc, Key Employees 14

List of Figures
Medeon Biodesign Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Medeon Biodesign Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Medeon Biodesign Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Medeon Biodesign Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Medeon Biodesign Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Medeon Biodesign Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Medeon Biodesign Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Medeon Biodesign Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Medeon Biodesign Inc (6499):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • David Lloyd Leisure Ltd:企業の戦略・SWOT・財務情報
    David Lloyd Leisure Ltd - Strategy, SWOT and Corporate Finance Report Summary David Lloyd Leisure Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Queen’s University Belfast:製薬・医療:M&Aディール及び事業提携情報
    Summary Queen's University Belfast (Queen’s University) is an educational institution that offers education and research services. The institute provides undergraduate, professional development and postgraduate programs. Its postgraduate programs comprise postgraduate diploma in nursing, MSc advance …
  • Trusted Media Brands, Inc.:企業の戦略的SWOT分析
    Trusted Media Brands, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Valeo Pharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Valeo Pharma Inc (Valeo Pharma), a subsidiary of Manitex Capital Inc, is a pharmaceutical company that offers healthcare solutions and specialty products. The company provides dermatology products such as drops, tablets, solutions, injections among others. It develops, licenses, and commerci …
  • WPG Holdings Limited:企業の戦略・SWOT・財務情報
    WPG Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary WPG Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Eguana Technologies Inc (EGT):企業の財務・戦略的SWOT分析
    Eguana Technologies Inc (EGT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Bachem Holding AG (BANB):製薬・医療:M&Aディール及び事業提携情報
    Summary Bachem Holding AG (Bachem) is a technology-based biochemical company which develops and manufactures peptides and complex organic molecules including active pharmaceutical ingredients and biochemicals for research purposes. Bachem offers its products and services to the pharmaceutical and bi …
  • Parker Hannifin Corp (PH):医療機器:M&Aディール及び事業提携情報
    Summary Parker Hannifin Corp (Parker) is a manufacturer of motion and control technologies and systems. The company offers critical motion and control solutions, including fluid power systems, electromechanical controls and related components. Its products find use in various industries and applicat …
  • OK Biotech Co Ltd (4155):医療機器:M&Aディール及び事業提携情報
    Summary OK Biotech Co Ltd (OK Biotech) is a medical device manufacturing and distribution company that manufactures and distributes blood glucose monitoring devices and homecare medical products, among others. The company’s blood glucose monitoring devices include blood glucose meter systems, blood …
  • MGM Resorts International:企業の戦略・SWOT・財務情報
    MGM Resorts International - Strategy, SWOT and Corporate Finance Report Summary MGM Resorts International - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Tufts Medical Center:医療機器:M&Aディール及び事業提携情報
    Summary Tufts Medical Center (TMC), formerly New England Medical Center Hospital Inc, a subsidiary of Tufts University School of Medicine, is an academic medical center that provides patient care services. The center offers treatments for brain tumor, breast cancer, cardiac arrhythmia, cardiomyopath …
  • Nuformix Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Nuformix Ltd (Nuformix) is a provider of pharmaceutical cocrystallisation products. The company develops and manufactures products in reprofiling, supergenerics and emerging markets areas. It offers methodologies for rational solid form discovery; and provides technologies for rapid solid fo …
  • GAIL (India) Limited:企業の戦略・SWOT・財務情報
    GAIL (India) Limited - Strategy, SWOT and Corporate Finance Report Summary GAIL (India) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Recordati Rare Diseases Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Recordati Rare Diseases Inc (RRD), a subsidiary of Recordati SpA is a biopharmaceutical company that discovers and develops orphan drugs and biologics. The company’s products comprise chemet, neoprofen, panhematin, desoxyn, mustargen, carbaglu, cosmegen, peganone and tranxene, among others. …
  • Cosmo Films Ltd:戦略・SWOT・企業財務分析
    Cosmo Films Ltd - Strategy, SWOT and Corporate Finance Report Summary Cosmo Films Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Tompkins Financial Corp (TMP):企業の財務・戦略的SWOT分析
    Tompkins Financial Corp (TMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Handok Inc (002390)-医療機器分野:企業M&A・提携分析
    Summary Handok Inc (Handok), formerly known as Handok Pharmaceuticals Co Ltd, is a pharmaceutical and health care company which develops, manufactures and distributes healthcare solutions. The company develops and provides pharmaceutical products including prescription drugs, OTC drugs, medical devi …
  • Panasonic Corp (6752):企業の財務・戦略的SWOT分析
    Panasonic Corp (6752) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Indivior Plc (INDV):企業の財務・戦略的SWOT分析
    Indivior Plc (INDV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Steel Reef Infrastructure Corp-石油・ガス分野:企業M&A・提携分析
    Summary Steel Reef Infrastructure Corp (Steel Reef) is a mid-stream company that focuses on long-term returns through investments in small to midsized infrastructure with focus on the Western Canadian Sedimentary Basin. The company carries out the construction, operation and optimization of oil and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆